Luncheon

Oct. 12 (Thu.) ,2017 12:00-13:00

Annex Hall
F205/F206

Simultaneous Interpretation

Japanese Session

【L-5】 Takeda Pharmaceutical

The establishment of Drug Discovery Ecosystem by partnership with industry, government and academia

In order to accelerate innovation in the drug discovery, we need to establish more effective collaboration framework among stakeholders; academia, bio-venture company, government and pharma company. It is also critical to address creation of "Drug Discovery Ecosystem" in which ideas from academia or bio-venture companies could become attractive source of innovative drugs in combination with drug R&D platforms and know-hows etc. provided by pharma companies.
This session will provide the detail and the feature plan about Drug Discovery Ecosystem (Shonan Health Innovation Park) which Takeda is pressing ahead.

Open Innovation and Drug Discovery Eco-system
-Takeda aims to establish more effective collaboration framework-

Haruhiko Hirate

Corporate Officer, Takeda Pharmaceutical

Shonan Health Innovation Park
-Novel Endeavor to Establishment of Drug Discovery Eco-system-

Yoshinori Ikeura

CEO, Axcelead Drug Discovery partners

Close Window